Characterization of domains of the phosphoriboprotein P0 of Plasmodium falciparum

Molecular and Biochemical Parasitology

Volumn 107, Issue 2, 2000, Pages 143-154

  Chatterjee, Sanchita ^a   Singh, Subhash ^a   Sohoni, Rashmi ^a   Kattige, Vidya ^a   Deshpande, Charusheela ^a   Chiplunkar, Shubhada ^b   Kumar, Nirbhay ^c   Sharma, Shobhona ^a  

^a TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

^b CANCER RESEARCH INSTITUTE   (India)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Immunogenicity; Malaria immunity; Plasmodium falciparum; Ribosomal phosphoprotein P0; Surface localization

Indexed keywords

PHOSPHOPROTEIN; PHOSPHORIBOPROTEIN; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOGENICITY; IN VITRO STUDY; MALARIA; MEROZOITE; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RABBIT; RIBOSOME;

ADULT; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MALARIA, FALCIPARUM; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; PLASMODIUM FALCIPARUM; RABBITS; RECOMBINANT FUSION PROTEINS; RIBOSOMAL PROTEINS; T-LYMPHOCYTES;

ORYCTOLAGUS CUNICULUS; PLASMODIUM FALCIPARUM;

EID: 0034656357     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-6851(99)00226-1     Document Type: Article

References (30)

1. Butler D., Maurice J., O'Brien C. Time to put malaria control on the global agenda. Nature. 386:1997;535-536.
2. Cohen S., Mcgregor I.A., Carrington S.P. Gammaglobulin and acquired immunity to human malaria. Nature. 192:1961;733-737.
3. Bouharoun-Tayoun H., Druihle P. P. falciparum malaria: evidence for an isotype imbalance which may be responsible for the delayed acquisition of protective immunity. Infect. Immun. 60:1992;1473-1481.
4. Bouharoun-Tayoun H., Oeuvray C., Lunel F., Druihle P. Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J. Exp. Med. 182:1995;409-418.
5. Oeuvray C., Bouharoun-Tayoun H., Grass-Masse H., Botitius E., Kaidoh T., Aikawa M., Filgueira M.-C., Tartar A., Druihle P. Merozoite surface protein 3; a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes. Blood. 84:1994;1594-1602.
6. Lobo C.A., Kar S.K., Ravindran B., Kabilan L., Sharma S. Novel proteins of Plasmodium falciparum identified by differential immunoscreening using immune and patient sera. Infect. Immun. 62:1994;651-656.
7. Goswami A., Chatterjee S., Sharma S. Cloning of a ribosomal phosphoprotein P0 gene homologue from Plasmodium falciparum. Mol. Biochem. Parasitol. 82:1996;117-120.
8. Goswami A., Singh S., Redkar V.D., Sharma S. Characterization of P0, a ribosomal phosphoprotein of Plasmodium falciparum. J. Biol. Chem. 272:1997;12138-12143.
9. Bouharoun-Tayoun H., Attanath P., Sabchareon A., Chongsuphajaisiddhi T., Druihle P. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in co-operation with monocytes. J. Exp. Med. 172:1990;1633-1641.
10. Levin M.J., Vazquez M., Kaplan D., Schijman A.G. The Trypanosoma cruzi ribosomal P protein family: classification and antigenicity. Parasitol. Today. 9:1993;381-384.
11. Skeiky Y.A.W., Benson D.R., Elwasila M., Badaro R., Burns Jr J.M., Reed S.G. Antigens shared by Leishmania species and Trypanosoma cruzi: immunological comparison of the acidic ribosomal P0 proteins. Infect. Immun. 62:1994;1643-1651.
12. Kaplan D., Ferrari I., Bergami P.L., Mahler E., Levitus G., Chiale P., Hoebeke J., Van Regenmortel M.H.V., Levin M. Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus. Proc. Natl. Acad. Sci. USA. 94:1997;10301-10306.
13. Soto M., Requena J.M., Quijada L., Guzman F., Patarroyo M.E., Alonso C. Identification of the Leishmania infantum P0 ribosomal protein epitope in canine visceral leishmaniasis. Immunol. Lett. 48:1995;23-28.
14. Elkon K., Skelly S., Parnassa A., Moller W., Danho W., Weissbach H., Brot N. Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA. 83:1986;7419-7423.
15. Smith D.B., Johnson K.S. Single step purification of polypeptides expressed in Escherichia coli as fusions with glutathione-S-transferase. Gene. 67:1988;31-40.
16. Ifediba T., Vandergerg J.P. Complete in vitro maturation of Plasmodium falciparum gametocytes. Nature. 294:1981;364-366.
17. Harlow E., Lane D. Antibodies - A Laboratory Manual. 1988;Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
18. Julius M.H., Simpson E., Herzenberg L.A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3:1973;645-649.
19. Blackman M.J. Purification of Plasmodium falciparum merozoites for the analysis of the processing of merozoite surface protein-1. Russell D.G. Methods in Cell Biology. 45:1994;213-220 Academic Press, London.
20. Fidock D., Nguyen T., Dodemont H., Wijnand M., Eling S., James A. Plasmodium falciparum ribosomal P2 protein gene expression is independent of the developmentally regulated rRNAs. Exp. Parasitol. 89:1998;125-128.
21. Roeffen W., Geeraedts F., Eling W., Beckers P., Kumar N., Lensen T., Sauerwein R. Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent. Infect. Immun. 63:1995;467-471.
22. Wizel B., Kumar N. Identification of a continuous and cross-reacting epitope for Plasmodium falciparum transmission-blocking immunity. Proc. Natl. Acad. Sci. USA. 88:1991;9533-9537.
23. Cohen S., Butcher G.A., Crandall R.B. Action of malarial antibody in vitro. Nature. 223:1969;368-371.
24. Koren E., Reichlin M.W., Kosec M., Fugate R.D., Reichlin M. Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells. J. Clin. Invest. 89:1992;1236-1241.
25. Uchiumi T., Wahha A.J., Traut R.R. Topography and stoichiometry of acidic proteins in large ribosomal subunits from Artemia salina as determined by cross linking. Proc. Natl. Acad. Sci. USA. 84:1987;5580-5584.
26. Elkon K.B., Bonfa E., Weissbach H., Brot N. Antiribosomal antibodies in SLE, infection, and following deliberate immunization. Adv. Exp. Med. Biol. 347:1994;81-92.
27. Rich B.E., Steitz J.A. Human acidic ribosomal phosphoproteins P0, P1 and P2: analysis of cDNA clones, in vitro synthesis and assembly. Mol. Cell. Biol. 7:1987;4065-4074.
28. Saenz-Robles M.T., Remacha M., Vilella M.D., Zinker S., Ballesta J.P.G. The acidic ribosomal proteins as regulators of the eukaryotic ribosomal activity. Biochim. Biophys. Acta. 1050:1990;51-55.
29. Uchiumi T., Kominami R. Direct evidence for interaction of the conserved GTPase domain within 28S RNA with mammalian ribosomal acidic phosphoproteins and L12. J. Biol. Chem. 267:1992;19179-19185.
30. Santos C, Ballesta JPG. Ribosomal protein P0, contrary to phosphoproteins P1 and P2, is required for ribosome activity and Saccharomyces cerevisiae viability, J. Biol. Chem. 1994; 269:15689-15696.